Mesa Laboratories, Inc. (MLAB)
NASDAQ: MLAB · Real-Time Price · USD
100.81
-0.23 (-0.23%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Mesa Laboratories Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
6.71-1.97-254.250.931.87
Depreciation & Amortization
23.2724.5331.5733.1325.07
Stock-Based Compensation
17.8713.1411.9412.5411.39
Other Adjustments
-0.034.21248.9-1.518.09
Change in Receivables
-3.21-2.934.94-2.12-6.75
Changes in Inventories
-4.431.152.56-10.18-1.05
Changes in Accounts Payable
-1.2-0.39-0.1-1.551.37
Changes in Accrued Expenses
3.59.5-1.24-3.360.26
Changes in Unearned Revenue
-0.26-0.94-0.410.612.59
Changes in Other Operating Activities
0.610.50.21-0.51-3.61
Operating Cash Flow
42.8346.8144.1327.9839.22
Operating Cash Flow Growth
-8.50%6.06%57.71%-28.66%5.80%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-3.25-4.25-2.57-4.54-4.43
Purchases of Intangible Assets
--0.25---
Cash Acquisitions
---78.74-4.95-300.79
Investing Cash Flow
-3.25-4.5-81.31-9.49-305.23

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
107.573.4771-70
Long-Term Debt Repaid
-134.25-115.81-33.5-36-21
Net Long-Term Debt Issued (Repaid)
-26.75-42.3537.5-3649
Issuance of Common Stock
-2.640.3678.03
Repurchase of Common Stock
-1.06-0.89-0.73-0.92-0.88
Net Common Stock Issued (Repurchased)
-1.061.76-0.376.087.15
Common Dividends Paid
-3.52-3.47-3.45-3.41-3.34
Other Financing Activities
-10.52-0.45-0.85--0.24
Financing Cash Flow
-41.85-44.5132.84-33.3352.58

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
1.881.31-0.36-1.6-1.09
Net Cash Flow
-0.39-0.89-4.7-16.44-214.52

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
39.5842.5641.5723.4434.79
Free Cash Flow Growth
-7.00%2.39%77.34%-32.63%-0.83%
FCF Margin
15.89%17.66%19.23%10.70%18.87%
Free Cash Flow Per Share
7.117.857.724.376.52
Levered Free Cash Flow
-1.8-14.21-186.71-21.4771.07
Unlevered Free Cash Flow
28.5824.7-220.915.6622.66
SEC Filings: 10-K · 10-Q